查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2047914

疫苗輸送裝置市場－全球產業規模、佔有率、趨勢、機會、預測：按裝置、給藥途徑、地區和競爭對手分類，2021-2031年

Vaccine Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By Route Of Administration, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球疫苗接種設備市場預計將從 2025 年的 79.2 億美元大幅成長至 2031 年的 119.7 億美元，複合年成長率為 7.13%。

這些器械，包括注射器、針頭、噴射注射器和微針貼片，是用於注射生物製藥的專用醫療器械。該市場的成長主要受全球感染疾病發病率上升以及政府主導的旨在實現全民免疫的大規模免疫宣傳活動運動的推動。全球衛生計畫的大規模採購也印證了對這些注射工具的巨大需求。例如，聯合國兒童基金會正在為其2024年免疫接種運動在全球供應8.8619億支注射器，凸顯了擴充性的注射系統在實現公共衛生目標方面發揮的關鍵作用。

市場概覽
預測期 2027-2031
市場規模：2025年 79.2億美元
市場規模：2031年 119.7億美元
複合年成長率：2026-2031年 7.13%
成長最快的細分市場 注射器
最大的市場 北美洲

然而，市場擴張的一大障礙在於如何妥善管理一次性醫療設備所產生的危險醫療廢棄物。廢棄針頭和注射器的處置會帶來嚴重的環境和安全風險，需要完善的廢棄物管理基礎設施。然而，此類基礎設施的建設往往需要大量資源，在開發中國家常常捉襟見肘。因此，確保安全處置和預防針刺傷所帶來的後勤和經濟負擔，成為傳統疫苗接種方法順利推廣和應用的重大障礙，尤其是在新興市場。

市場促進因素

微針和無針注射系統的技術進步正在從根本上改變全球疫苗輸送設備市場，克服物流障礙並提高患者依從性。這些創新技術，特別是高密度微陣列貼片，非常適合在資源匱乏的環境中部署，因為它們無需低溫運輸儲存和專業人員操作。向這種微創解決方案的轉變正在加速其商業化進程，並推動大量投資以擴大生產能力。例如，BioSpace在2025年8月報道稱，Vaxxas已獲得約9,000萬澳元的資金，用於推進其專有貼片技術的研發。這表明，整個產業正致力於從傳統的針頭和注射器方法轉向更具擴充性、更易於使用且能增強免疫效力的替代方案。

同時，全球免疫舉措的擴展和政府的財政支持是推動市場規模成長的主要因素，加速了為實現全民健康覆蓋（UHC）目標而採購的注射器械。國際組織和各國政府正在加強力，透過積極的宣傳活動為未接種疫苗的兒童接種疫苗，並防治可預防疾病。 2025年7月，世界衛生組織（世衛組織）報告稱，2024年全球第一線人類乳突病毒（HPV）疫苗接種率達到31%，顯示各國正集中精力擴大預防性醫療保健服務的覆蓋範圍。為了支持這些大規模項目，製造商正在大幅提升產能。例如，2025年1月，BD公司將國內安全型注射器材的產能提高了40%以上，以滿足醫療系統日益成長的需求。

市場挑戰

一次性疫苗接種系統產生的危險醫療廢棄物的有效處置是全球疫苗接種設備市場成長的一大障礙。隨著免疫接種工作逐步推進，力求實現全民覆蓋，使用過的注射器和針頭數量不斷增加，造成了嚴重的物流和資金瓶頸，尤其是在開發中國家往往缺乏完善的處置基礎設施。這種短缺迫使醫療系統將大量資金用於廢棄物處置和控制，而不是用於購買更多的接種設備，導致市場滲透速度放緩，供應鏈運作更加複雜。

此外，這些危險物質的堆積所帶來的操作風險直接阻礙了傳統疫苗輸送裝置的順利分發。世界衛生組織（世衛組織）在2024年下半年報告稱，全球每年約160億次注射產生的銳器廢棄物中，有相當一部分未能得到安全處置。如此大量的生物危害性物質帶來了嚴重的監管風險和安全責任，阻礙了疫苗在資源匱乏地區的市場滲透。因此，無法以經濟有效的方式管理這些醫療設備的整個生命週期，成為限制因素，限制了整體市場成長潛力。

市場趨勢

鼻腔和黏膜疫苗遞送系統的擴展是關鍵的新趨勢，其驅動力在於需要在病毒入侵的初始部位建立強大的免疫力。與主要提供全身保護的傳統注射疫苗不同，這些創新的黏膜平台能夠誘發局部免疫反應，例如在呼吸道和胃腸道中產生IgA，這對於預防感染至關重要。口服製劑的開發進一步加速了這一轉變，它消除了人們對針頭的恐懼，並簡化了給藥流程。為了佐證其有效性，Vaxart公司於2025年9月報告稱，其第二代諾羅病毒口服候選疫苗在特定毒株的阻斷抗體水平上顯示出統計學意義上的顯著提升，分別提高了141%和94%，從而強調了黏膜給藥的有效性。

同時，隨著具備先進安全功能的預填充式注射器日益普及，製造業正轉向優先考慮規模化生產和快速部署。這一趨勢的特點是採用吹灌封 (BFS) 技術，該技術將器械成型、填充和密封整合到一個連續的製程中，與玻璃製品相比，從而降低了污染風險並簡化了供應鏈的複雜性。這種轉變既滿足了全球衛生指南要求的大規模生產，也確保了劑量的準確性。例如，ApiJect Systems 公司於 2025 年 5 月宣布了一項新的戰略合作夥伴關係，旨在建立一條年產能約為 2.5 億至 3 億支的生產線，這凸顯了整個行業對先進預填充解決方案的堅定承諾。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球疫苗輸送裝置市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 設備類型（注射器、噴射注射器）
    • 給藥途徑（皮內、肌肉內、皮下）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美疫苗輸送裝置市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲疫苗輸送設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區疫苗輸送裝置市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲疫苗輸送裝置的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲疫苗輸送設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球疫苗輸送裝置市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton Dickinson & Company
  • Bioject Medical Technologies, Inc.
  • PharmaJet, Inc.
  • Vaxxas, Inc.
  • Gerresheimer AG
  • SCHOTT AG
  • Corium, LLC
  • 3M Company
  • Croda International Plc
  • Meiji Holdings Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27507

The global market for vaccine delivery devices is projected to expand significantly, rising from USD 7.92 billion in 2025 to USD 11.97 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.13%. These devices, including syringes, needles, jet injectors, and microneedle patches, are specialized medical tools used to administer immunobiological agents. This market growth is primarily driven by the increasing worldwide incidence of infectious diseases and extensive government-backed immunization campaigns focused on achieving universal coverage. The considerable need for these administration tools is evident in the large-scale procurements for global health programs; for instance, UNICEF supplied 886.19 million syringes globally for vaccination efforts in 2024, highlighting the essential role of scalable delivery systems in fulfilling public health objectives.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 7.92 Billion
Market Size 2031USD 11.97 Billion
CAGR 2026-20317.13%
Fastest Growing SegmentSyringes
Largest MarketNorth America

Nevertheless, a major obstacle hindering market expansion is the complex issue of managing hazardous medical waste produced by single-use devices. The disposal of spent needles and syringes presents serious environmental and safety hazards, demanding sophisticated waste management infrastructure that often requires significant resources and is frequently inadequate in developing countries. As a result, the logistical and financial strains linked to ensuring safe disposal and preventing needle-stick injuries represent a critical impediment to the smooth distribution and uptake of traditional vaccine delivery methods, particularly in emerging markets.

Market Driver

Technological progress in microneedle and needle-free injection systems is fundamentally transforming the Global Vaccine Delivery Devices Market by overcoming logistical hurdles and enhancing patient adherence. These innovations, especially high-density microarray patches, remove the requirements for cold-chain storage and professional administration, making them highly suitable for deployment in resource-limited environments. This move towards less invasive solutions is attracting substantial investment to speed up their commercialization and increase manufacturing capacity. For instance, BioSpace reported in August 2025 that Vaxxas secured around AUD 90 million to advance its proprietary patch technology, indicating the industry's dedication to shifting from conventional needle-and-syringe methods to more scalable, user-friendly alternatives that boost immunological effectiveness.

Simultaneously, the expansion of global immunization initiatives and governmental financial support serves as a key driver for market volume, stimulating the procurement of delivery devices to achieve universal health objectives. International organizations and national governments are intensifying efforts to vaccinate "zero-dose" children and combat preventable diseases through vigorous campaigns. The World Health Organization reported in July 2025 that global coverage for the first dose of the human papillomavirus (HPV) vaccine reached 31% in 2024, demonstrating a focused drive to broaden access to preventative care. To support these extensive programs, manufacturers are significantly expanding their production capabilities; for example, BD increased its domestic manufacturing capacity for safety-engineered injection devices by over 40% in January 2025 to meet the growing demands of the healthcare system.

Market Challenge

The efficient handling of hazardous medical waste produced by single-use vaccine delivery systems poses a significant obstacle to the growth of the Global Vaccine Delivery Devices Market. As immunization efforts expand to achieve universal coverage, the resulting increase in used syringes and needles creates a considerable logistical and financial bottleneck, especially in developing economies where adequate disposal infrastructure is often lacking. This shortfall compels healthcare systems to allocate vital funds toward waste treatment and containment rather than acquiring more delivery units, thus slowing market adoption and complicating supply chain operations.

Moreover, the operational risks linked to this accumulation of hazardous materials directly impede the smooth distribution of traditional vaccine tools. The World Health Organization reported in late 2024 that out of approximately 16 billion injections administered globally, a substantial portion of the resulting sharps waste was not safely disposed of. This immense volume of bio-hazardous material introduces severe regulatory and safety liabilities, discouraging market penetration in regions with limited resources. Consequently, the inability to manage the entire lifecycle of these devices cost-effectively serves as a critical limitation, curbing the market's overall growth potential.

Market Trends

A significant emerging trend is the expansion of intranasal and mucosal vaccine delivery systems, driven by the necessity to build strong immunity at the initial sites of viral entry. Unlike conventional injectable vaccines that primarily offer systemic protection, these innovative mucosal platforms induce localized immune responses, such as IgA production in the respiratory and gastrointestinal tracts, which are crucial for preventing transmission. This shift is further propelled by the development of oral formats, which eliminate needle-phobia and simplify administration logistics. Confirming their effectiveness, Vaxart, Inc. reported in September 2025 that its second-generation oral vaccine candidates for norovirus demonstrated statistically significant increases in blocking antibodies of 141% and 94% against specific strains, underscoring the power of mucosal delivery.

Concurrently, the increasing prevalence of prefilled syringes equipped with advanced safety features is transforming the manufacturing sector to prioritize scalability and quick deployment. This trend is marked by the adoption of Blow-Fill-Seal (BFS) technology, which combines device formation, filling, and sealing into one continuous process, thereby lowering contamination risks and simplifying supply chain complexities compared to glass alternatives. This transition supports the high-volume production required for global health directives while ensuring precise dosage. As an illustration of this industrial scaling, ApiJect Systems, Corp. announced in May 2025 a new strategic partnership to install manufacturing lines capable of producing approximately 250 to 300 million units annually, highlighting a substantial industry commitment to advanced prefilled solutions.

Key Market Players

  • Becton Dickinson & Company
  • Bioject Medical Technologies, Inc.
  • PharmaJet, Inc.
  • Vaxxas, Inc.
  • Gerresheimer AG
  • SCHOTT AG
  • Corium, LLC
  • 3M Company
  • Croda International Plc
  • Meiji Holdings Co., Ltd.

Report Scope

In this report, the Global Vaccine Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vaccine Delivery Devices Market, By Device

  • Syringes
  • Jet Injectors

Vaccine Delivery Devices Market, By Route Of Administration

  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination

Vaccine Delivery Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vaccine Delivery Devices Market.

Available Customizations:

Global Vaccine Delivery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vaccine Delivery Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device (Syringes, Jet Injectors)
    • 5.2.2. By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Vaccine Delivery Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device
    • 6.2.2. By Route Of Administration
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vaccine Delivery Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device
        • 6.3.1.2.2. By Route Of Administration
    • 6.3.2. Canada Vaccine Delivery Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device
        • 6.3.2.2.2. By Route Of Administration
    • 6.3.3. Mexico Vaccine Delivery Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device
        • 6.3.3.2.2. By Route Of Administration

7. Europe Vaccine Delivery Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device
    • 7.2.2. By Route Of Administration
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Vaccine Delivery Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device
        • 7.3.1.2.2. By Route Of Administration
    • 7.3.2. France Vaccine Delivery Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device
        • 7.3.2.2.2. By Route Of Administration
    • 7.3.3. United Kingdom Vaccine Delivery Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device
        • 7.3.3.2.2. By Route Of Administration
    • 7.3.4. Italy Vaccine Delivery Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device
        • 7.3.4.2.2. By Route Of Administration
    • 7.3.5. Spain Vaccine Delivery Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device
        • 7.3.5.2.2. By Route Of Administration

8. Asia Pacific Vaccine Delivery Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device
    • 8.2.2. By Route Of Administration
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vaccine Delivery Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device
        • 8.3.1.2.2. By Route Of Administration
    • 8.3.2. India Vaccine Delivery Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device
        • 8.3.2.2.2. By Route Of Administration
    • 8.3.3. Japan Vaccine Delivery Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device
        • 8.3.3.2.2. By Route Of Administration
    • 8.3.4. South Korea Vaccine Delivery Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device
        • 8.3.4.2.2. By Route Of Administration
    • 8.3.5. Australia Vaccine Delivery Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device
        • 8.3.5.2.2. By Route Of Administration

9. Middle East & Africa Vaccine Delivery Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device
    • 9.2.2. By Route Of Administration
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Vaccine Delivery Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device
        • 9.3.1.2.2. By Route Of Administration
    • 9.3.2. UAE Vaccine Delivery Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device
        • 9.3.2.2.2. By Route Of Administration
    • 9.3.3. South Africa Vaccine Delivery Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device
        • 9.3.3.2.2. By Route Of Administration

10. South America Vaccine Delivery Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device
    • 10.2.2. By Route Of Administration
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Vaccine Delivery Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device
        • 10.3.1.2.2. By Route Of Administration
    • 10.3.2. Colombia Vaccine Delivery Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device
        • 10.3.2.2.2. By Route Of Administration
    • 10.3.3. Argentina Vaccine Delivery Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device
        • 10.3.3.2.2. By Route Of Administration

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vaccine Delivery Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton Dickinson & Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bioject Medical Technologies, Inc.
  • 15.3. PharmaJet, Inc.
  • 15.4. Vaxxas, Inc.
  • 15.5. Gerresheimer AG
  • 15.6. SCHOTT AG
  • 15.7. Corium, LLC
  • 15.8. 3M Company
  • 15.9. Croda International Plc
  • 15.10. Meiji Holdings Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer